Table 1.
Group | Body weight(g) | Organ index (mg/g) | ||
---|---|---|---|---|
Spleen index | Thymus index | Kidney index | ||
Blank control | 36.82 ± 1.55 | 1.87 ± 0.23 | 1.45 ± 0.21 | 10.68 ± 0.56 |
D-gal | 29.06 ± 2.24△ | 1.54 ± 0.24△ | 1.16 ± 0.15△ | 8.01 ± 1.32△ |
VE (150 mg/kg) | 34.96 ± 2.67** | 1.78 ± 0.15** | 1.39 ± 0.18** | 9.95 ± 1.29* |
EA-L (50 mg/kg) | 32.4 ± 2.80*△ | 1.55 ± 0.28*△ | 1.18 ± 0.14△ | 8.29 ± 0.89△ |
EA-M (100 mg/kg) | 35.03 ± 2.26** | 1.86 ± 0.19** | 1.45 ± 0.19** | 9.10 ± 0.94* |
EA-H (150 mg/kg) | 36.74 ± 1.49** | 1.98 ± 0.33** | 1.47 ± 0.15** | 9.86 ± 0.80* |
Notes: Dates are given as mean ± SD (n = 8). △P < 0.05 and △△P < 0.01 vs blank control
group. *P < 0.05 and **P < 0.01 vs D-gal model group.
EA-H: high-dose EA-treated group, EA-M: the medium-dose EA group.
EA-L: the low-dose EA-treated group.